Uganda Launches Largest Trial of Experimental Ebola Vaccine As Outbreak Spreads in Neighboring Congo

(KAMPALA, Uganda) — Researchers in Uganda have launched the largest-ever trial of the experimental Ebola vaccine that is expected to be deployed in neighboring Congo, where a deadly outbreak has killed over 1,800 people. The trial of the Janssen Pharmaceuticals vaccine involves up to 800 people in the western district of Mbarara and is supported by Doctors without Borders and the London School of Hygiene and Tropical Medicine. Pontiano Kaleebu, a Ugandan researcher who leads the trial, said Friday that he regrets that the Janssen vaccine has not yet been deployed in Congo. The health minister there who stepped down last month had argued against its deployment, saying a second vaccine could create confusion on the ground. Already more than 180,000 people in Congo’s yearlong outbreak have received an experimental but effective Merck vaccine, but health experts worry about the availability of doses as the virus now spreads in a major city, Goma, along the Rwanda border. The wife and 1-year-old daughter of the man who died this week of Ebola in Goma now have the disease. Both the wife and child were doing well in treatment, Congo’s new Ebola response coordinator, Jean-Jacques Muyembe, told reporters on Friday. But he warned that about half of the cases in this outbreak are going undetected and at that rate “this epidemic could last two or three years.” The current goal is to strengthen surveillance and bring the detection rate to 80%, he said. Healt...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized congo ebola onetime Uganda vaccine Source Type: news